United States · FDA National Drug Code directory
Oxaliplatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-6132_3960461c-958a-43c1-a685-522039b021df
- Product NDC
- 60505-6132
- Form
- INJECTION, SOLUTION
- Composition / generic term
- oxaliplatin
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170104
- Source listing expiry
- 20261231
Source-listed ingredients
- OXALIPLATIN — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (60505-6132-6) / 10 mL in 1 VIAL · 60505-6132-6
- 1 VIAL in 1 CARTON (60505-6132-7) / 20 mL in 1 VIAL · 60505-6132-7
- 1 VIAL in 1 CARTON (60505-6132-8) / 40 mL in 1 VIAL · 60505-6132-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →